Andria L. Del Tredici

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Kimberly E. Vanover, David M. Weiner, Malath Makhay et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 196 citations · Full text

Frequency of CYP2D6 Alleles Including Structural Variants in the United States

Andria L. Del Tredici, Alka Malhotra, Matthew Dedek et al. · Frontiers in Pharmacology · 2018 · 124 citations · Full text

Recommendations for Clinical Warfarin Genotyping Allele Selection

Victoria M. Pratt, Larisa H. Cavallari, Andria L. Del Tredici et al. · Journal of Molecular Diagnostics · 2020 · 65 citations · Full text

Thrombosis, Allelic Variant, Genetic Epidemiology +5

Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist

Fabrice Piu, Cindy Cheevers, Lene Hyldtoft et al. · European Journal of Pharmacology · 2008 · 40 citations

Broad Modulation, Pain Syndrome, Pain Medicine +11

Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes

Andria L. Del Tredici, Carsten Andersen, Erika A. Currier et al. · Molecular Pharmacology · 2007 · 38 citations